AMD3100 plus G-CSF use in proven poor mobilizers in a compassionate use protocol (CUP).

被引：1

作者：

McGuirk, J

McCarty, J

Gibb, K

Badel, K

Bridger, G

Calandra, G

机构：

[1] Kansas City Canc Ctr, BMT Program, Kansas City, MO USA

[2] Virginia Commonwealth Univ, BTM Program, Massey Canc Ctr, Richmond, VA USA

[3] AnorMED Inc, Langley, BC, Canada

来源：

BLOOD | 2005年 / 106卷 / 11期

关键词：

D O I：

10.1182/blood.V106.11.154.154

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

154

引用

页码：49A / 49A

页数：1

共 50 条

[41] AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data
G Calandra
J McCarty
J McGuirk
G Tricot
S-A Crocker
K Badel
B Grove
A Dye
G Bridger
Bone Marrow Transplantation, 2008, 41 : 331 - 338
[42] AMD3100 plus G-CSF can successfully mobilize CD34+cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data
Calandra, G.
McCarty, J.
McGuirk, J.
Tricot, G.
Crocker, S-A
Badel, K.
Grove, B.
Dye, A.
Bridger, G.
BONE MARROW TRANSPLANTATION, 2008, 41 (04) : 331 - 338
[43] Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy
Humbert, Olivier
Chan, Frieda
Rajawat, Yogendra S.
Torgerson, Troy R.
Burtner, Christopher R.
Hubbard, Nicholas W.
Humphrys, Daniel
Norgaard, Zachary K.
O'Donnell, Patricia
Adair, Jennifer E.
Trobridge, Grant D.
Scharenberg, Andrew M.
Felsburg, Peter J.
Rawlings, David J.
Kiem, Hans-Peter
BLOOD ADVANCES, 2018, 2 (09) : 987 - 999
[44] The CXCR4 antagonist AMD3100 mobilizes a more primitive subset of CD34+cells than G-CSF
Seeger, T
Veldwijk, M
Bridger, G
Calandra, G
Goldschmidt, H
Ho, A
Fruehauf, S
BLOOD, 2005, 106 (11) : 558A - 558A
[45] Efficacy and safety of stem cell mobilization with etoposide plus cytarabine plus G-CSF in poor mobilizers with relapsed or refractory lymphoma
Zhu, Zhijuan
Li, Xiaofan
Yuan, Xiaohong
Chen, Xianling
Lin, Ting
Guo, Xiangli
Li, Nainong
FRONTIERS IN IMMUNOLOGY, 2024, 15
[46] Biomarker discovery, safety and feasibility of G-CSF compassionate use in ALS patients
Johannesen, S.
Baldaranov, D.
Khomenko, A.
Blume, J.
Kassubek, J.
Mueller, H. -P.
Kobor, I.
Bruun, T.
Grassinger, J.
Schuierer, G.
Schulte-Mattler, W.
Schneider, A.
Deppe, M.
Bogdahn, U.
EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 142 - 142
[47] Allograft cell content and GVHD differ in murine recipients of AMD3100 versus G-CSF mobilized peripheral blood stem cells.
Lundqvist, A
Hamoui, N
Andersson, J
Elshal, M
Takahashi, Y
Srinivasan, R
Suffredini, D
Mccoy, PJ
Childs, R
BLOOD, 2005, 106 (11) : 869A - 869A
[48] AMD3100联合G-CSF对糖尿病小鼠骨髓内皮祖细胞的动员作用
林晓莹
汪虹
重庆医科大学学报, 2019, 44 (03) : 247 - 254
[49] Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)—Polish compassionate use experience
Grzegorz Wladyslaw Basak
Wanda Knopinska-Posluszny
Magdalena Matuszak
Elzbieta Kisiel
Dorota Hawrylecka
Anna Szmigielska-Kaplon
Donata Urbaniak-Kujda
Jaroslaw Dybko
Patrycja Zielinska
Anna Dabrowska-Iwanicka
Joanna Werkun
Piotr Rzepecki
Wiktoria Wroblewska
Wieslaw Wiktor-Jedrzejczak
Annals of Hematology, 2011, 90 : 557 - 568
[50] Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experience
Basak, Grzegorz Wladyslaw
Knopinska-Posluszny, Wanda
Matuszak, Magdalena
Kisiel, Elzbieta
Hawrylecka, Dorota
Szmigielska-Kaplon, Anna
Urbaniak-Kujda, Donata
Dybko, Jaroslaw
Zielinska, Patrycja
Dabrowska-Iwanicka, Anna
Werkun, Joanna
Rzepecki, Piotr
Wroblewska, Wiktoria
Wiktor-Jedrzejczak, Wieslaw
ANNALS OF HEMATOLOGY, 2011, 90 (05) : 557 - 568

← 1 2 3 4 5 →